期刊文献+

慢性肾病继发甲状旁腺功能亢进的手术和药物治疗疗效分析 被引量:10

Efficacy analysis of medical and surgical treatments in chronic k idney disease patients with secondary hyperparathyroidism
下载PDF
导出
摘要 目的比较手术和药物治疗继发性甲状旁腺功能亢进症(secondary hyperparathyroidism,SHPT)的疗效。方法回顾性分析同济医院2013年1月~2017年6月收治的137例SHPT患者的临床资料,比较不同治疗方式前后患者临床特征及复发情况。结果手术组53例患者,平均透析时长(78.0±4.9)个月;药物组84例,平均透析时长(62.0±6.4)个月。治疗后两组血清全段甲状旁腺激素(intact parathyroid hormone,i PTH)均有下降,但手术组下降幅度更显著,且远期效果满意[3年后为(67.4±7.4)pg/ml]。手术组血清钙下降较明显,药物组无明显下降。复发率手术组为7.5%,药物组为15.5%,且药物组5例(5.9%)患者出现持续性甲状旁腺功能亢进。结论手术是治疗SHPT的有效方法,即使对于病情更复杂的患者也能在不增加并发症风险的前提下获得满意疗效。 OBJECTIVE To investigate the effects of surgical and medical treatments on chronic kidney disease (CKD) patients with secondary hyperparathyroidism (SHPT). METHODS A total of 137 CKD patients with SHPT in Tongji Hospital from 2013 to 2017 were collected in this systematic retrospective study. We compared the improvement of clinical symptoms and recurrence rate before and after treatment. RESULTS Surgical group was comprised of 53 patients and received maintenance dialysis for average (78.0±4.9) months, while medical group was comprised of 84 patients and received maintenance dialysis for average (62.0±6.4) months. After treatment, the average in tact parathyroid hormone (iPTH) in both groups reduced significantly (surgical group: P<0.001, medical group: P=0.037). The serum iPTH in surgical group was decreased apparently compared with medical group (P=0.015) and maintained satisfied result during the 3 years of follow-up [(67.4±7.4) pg/ml]. The reduction of average serum corrected calcium was more significant in surgical group (P=0.001), while there was no obvious decrease in medical group (P=0.443). The recurrence rate in surgical group was 7.5% and in medical group was 15.5%(P=0.024). Beyond that, 5 (5.9%) patients suffered persistent hyperparathyroidism in medical group. CONCLUSION Surgical treatment is an effective way to control serum iPTH and calcium chronically for SHPT patients. In addition, complex SHPT patients can also receive satisfied outcome by surgical treatment, without increasing risk of complication.
作者 黄雅静 胡晓鹏 吴亚群 罗智勇 HUANG Yajing;HUXiaopeng;WU Yaqun;LUO Zhiyong(Department of Thyroid and Breast Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China)
出处 《中国耳鼻咽喉头颈外科》 CSCD 2019年第3期134-137,共4页 Chinese Archives of Otolaryngology-Head and Neck Surgery
基金 国家自然科学基金资助项目(81502373)
关键词 甲状旁腺切除术 甲状旁腺功能亢进症 继发性 治疗结果 慢性肾脏病 西那卡塞 Parathyroidectomy Hyperparathyroidism, Secondary Treatment Outcome chronic kidney disease cinacalcet
  • 相关文献

参考文献3

二级参考文献38

  • 1刘君,王家东.甲状旁腺切除术治疗继发性甲状旁腺功能亢进[J].中国耳鼻咽喉头颈外科,2005,12(7):427-429. 被引量:6
  • 2周建平,田雨霖.中国人原发性甲状旁腺功能亢进10年文献回顾(1995~2004年)[J].中国普通外科杂志,2007,16(1):78-80. 被引量:44
  • 3孟迅吾,沙利进.原发性甲状旁腺功能亢进症[M]//史轶蘩.协和内分泌代谢学.北京:科学出版社,1999:1464-1477.
  • 4廖二元.原发性甲状旁腺功能亢进症[M]//廖二元,曹旭.湘雅代谢性骨病学.北京:科学出版社,2003:660-700.
  • 5孟迅吾,王鸥.原发性甲状旁腺功能亢进症[M]//陈家伦.临床内分泌学.上海:上海科学技术出版社,2011:1365-1370.
  • 6Silverberg SJ.Primary hyperparathyroidism[M]//Rosen CJ.Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.8th ed.Danvers,MA01923,USA:A John Wiley&Sons,2013:543-552.
  • 7Bringhurst FR,Demay MB,Kronenberg HM.Hormones and disorders of mineral metabolism[M]//Kronenberg HM.Williams Textbook of Endocrinology.11th ed.Philadelphia:Saunders Elsevier,2008:1203-1268.
  • 8Zhao L,Liu JM,He XY,et al.The changing clinical patterns of primary hyperparathyroidism in Chinese patients:data from 2000 to 2010 in a single clinical center[J].J Clin Endocrinol Metab,2013,98:721-728.
  • 9Sharretts JM,Simonds WF.Clinical and molecular genetics of parathyroid neoplasms[J].Best Pract Res Clin Endocrinol Metab,2010,24;491-502.
  • 10Arnold A,Marx SJ.Familial primary hyperparathyroidism[M]//Rosen CJ.Primer on the metabolic bone diseases and disorders of mineral metabolism.8th ed.Danvers,MA01923,USA:A John Wiley&Sons,2013:553-561.

共引文献300

同被引文献85

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部